Skip to main content
AJOG Global Reports logoLink to AJOG Global Reports
. 2025 Feb 24;5(2):100467. doi: 10.1016/j.xagr.2025.100467

Accuracy of ultrasound in prediction of abnormal placental adherence: a systematic review and meta-analysis

Ekramy A Mohamed 1, Ruqayyah Ali Ahmed 2, Nada Yasser Metwali 2, Jumana Hussain Timraz 2, Ahmed Mohamed 3, Hossam Abdelfatah Mansour 4,
PMCID: PMC11976229  PMID: 40201618

Abstract

Background

The accuracy of ultrasound in detecting invasive placentation, such as placenta accreta spectrum (PAS), remains a topic of debate. Accurate prenatal diagnosis is crucial to improve maternal outcomes, especially in women with high-risk factors..

Objective

This systematic review and meta-analysis aimed to evaluate the diagnostic accuracy of ultrasonography in predicting invasive placentation among at-risk pregnant women.

Study Design

A comprehensive search of multiple databases (MEDLINE, EMBASE, Cochrane Library, etc.) was conducted to identify studies assessing the diagnostic accuracy of ultrasound in detecting PAS. A total of 24 studies, including 1,509 high-risk pregnancies, met the inclusion criteria. Data on sensitivity, specificity, positive likelihood ratio (LR+), negative likelihood ratio (LR-), and diagnostic odds ratio (DOR) were extracted and analyzed.

Results

The meta-analysis demonstrated that ultrasound has a high diagnostic performance, with a pooled sensitivity of 91.73% (95% CI: 88.3–94.7%) and specificity of 97.95% (95% CI: 97.4–98.6%). The DOR was 99.6 (95% CI: 49.9–200.1). Among ultrasound modalities, color Doppler showed the highest predictive accuracy with a sensitivity of 91.75% (95% CI: 86.3–95.6%) and specificity of 87.69% (95% CI: 85.7–91.5%).

Conclusion

Ultrasound, especially with the use of color Doppler, is highly effective in the prenatal diagnosis of PAS disorders in high-risk pregnancies. Early detection through ultrasound allows for better clinical management, reducing maternal morbidity by enabling planned interventions.

Key words: color Doppler, placenta accreta spectrum, prenatal diagnosis, ultrasound


AJOG Global Reports at a Glance.

Why was this study conducted?

This study was conducted in order to evaluate the ultrasound's diagnostic accuracy, specifically color Doppler, in the prediction of placenta accreta spectrum (PAS) in high-risk pregnancies. Accurate diagnosis is critical for the improvement of maternal outcomes.

Key findings

Key findings indicate that ultrasound has a pooled sensitivity of 91.73% and a specificity of 97.95%, with color Doppler demonstrating the highest predictive accuracy. Early detection through ultrasound enables better clinical management, which can reduce maternal morbidity.

What does this study add to what is known?

The study adds robust evidence to the existing literature by confirming the high diagnostic performance of ultrasound in the detection of PAS. It emphasizes the benefit of color Doppler in improving diagnostic precision, offering valuable guidance for clinicians in managing high-risk pregnancies. This supports the standardized usage of ultrasound for prenatal PAS diagnosis in appropriate care settings.

Introduction

The pathological adhesion of the placenta due to localized or widespread aberrant trophoblast invasion into the myometrium is known as placenta accreta spectrum (PAS), or morbidly adherent placenta (MAP).1 Over time, the rate of PAS is rising. In the 1970s and 1980s, it was estimated to be between 1 in 2510 and 1 in 4017, and between 1982 and 2002, it reached 1 in 533.2

The term “placenta accreta” describes a placenta that is difficult to separate from the uterine wall. It is still uncertain how exactly placental attachment abnormalities begin, although it is most likely more complex than just incorrect decidualization of a scarred region or absence of decidua in the lower uterine segment close to the cervix.3 PAS is characterized by an aberrant invasion of placental tissue (trophoblast) through the uterine serosa (referred to as accreta, increta, or percreta, respectively) into the inner or outer myometrium. Seven to 10 percent of maternal deaths are caused by this potentially fatal disease. The placenta becomes morbidly adherent when the decidua basalis and Nitabuch layer are absent, either completely or partially. Three forms of PAS are distinguished based on the extent of chorionic villi penetration: accrete, increta, and percreta.4

Significantly higher rates of cesarean sections are the cause of the considerable increase in placenta accreta occurrence. A previous cesarean birth, an accompanying placenta previa, and most likely a combination of the 2 are the 2 most significant risk factors. Additional risk factors include multiparity, advanced maternal age, prior uterine surgery such as curettage and dilatation, prior myomectomy (resulting in intrauterine adhesion, etc.), and more.5 A greater level of clinical suspicion is needed to diagnose PAS, and imaging can be a useful diagnostic technique. Ultrasonography is mostly used to identify placenta accreta, although it can occasionally fail to forecast the condition's prognosis, which can result in severe bleeding or even maternal mortality from insufficient preoperative assessment.6 It is commonly known that the best technique for precisely locating the placenta is transvaginal sonography (TVS). Even in cases of vaginal bleeding, TVS is safe for women with placenta previa. Clinical care can be guided and the diagnosis established with the use of appropriate antenatal ultrasonography. Grayscale sonography obtained in the second and third trimesters characteristics include the loss of a hypoechoic zone (myometrial zone) between the placenta and the myometrium, many vascular lacunae (irregular vascular spaces) within the placenta that give the appearance of Swiss cheese, the placental/myometrial site bulging into the bladder, and increased vascularity visible on color Doppler sonography.7

To maximize maternal outcomes, antenatal diagnosis of PAS is essential, and delivery should be scheduled at a level III or IV maternal care facility.8 The majority of women are diagnosed with PAS in the second or third trimester, despite the fact that ultrasonographic indications of the condition may be observed as early as the first trimester.9 Several placental vascular lacunae inside the retroplacental clear zone, myometrial thinning (less than 1 mm), disruption of the serosa–bladder interface, and placental extension into the myometrium, serosa, or bladder are among the gray scale criteria.10 Variations exist in ultrasound accuracy throughout several research. While some produced results with 100% accuracy, some reported substantially lower levels.11

This systematic review and meta-analysis study aims to evaluate the diagnostic accuracy of ultrasonography in the prediction of invasive placentation among at-risk pregnant women.

Methods

Study Aim: The purpose of this meta-analysis and systematic review was to evaluate the accuracy of ultrasonography in predicting aberrant placenta adhesion throughout the second trimester. Our study was registered in PROSPERO by the ID: CRD42024609696.

Design of Operations: This research is a meta-analysis.

Gathering and analyzing data: A thorough search for papers published in English was conducted across several databases. Using keywords associated with obstetric ultrasonography, placenta accrete spectrum, and morbidly adherent placenta, a computerized study was conducted in the databases of PubMed, Medline, Elsevier, Scopus, Google Scholar, and the Cochrane Library.

Study Selection: In this meta-analysis, we included studies which fulfilled the following criteria:

  • a.

    Randomized controlled trials (RCTs)

  • b.

    Singleton pregnancy.

  • c.

    Previous one or more CSs.

  • d.

    Gestational age from 14 week (last menstrual period and/ or Ultrasound confirmation of gestational age).

  • e.

    Patient diagnosed as having anterior placenta previa.

  • f.

    Studies reporting pregnancy outcomes

Exclusion Criteria:

  • a.

    Multiple gestational pregnancies.

  • b.

    Fundal placenta.

  • c.

    Primigravida.

  • d.

    Gestational age less than 14 week.

  • e.

    Posterior placenta previa.

  • f.

    Multipara with previous vaginal delivary.

  • g.

    Non-English publications

  • h.

    Studies with data with inadequate randomization.

The prediction of placenta accreta is dependent upon two or more of the following sonographic findings:

  • 1.

    Any portion of the echolucent region between the uterus and placenta that is obliterated is referred to as the "obliteration of the clear space."

  • 2.

    The placenta's many linear, irregular vascular gaps, known as placental lacunae, are seen.

  • 3.

    An abnormal serosa occurs when the typical continuous echolucent line is interrupted by a series of dashes at the contact between the uterus and the posterior bladder wall.

  • 4.

    Focused exophytic tumors that invade the bladder are present.

  • 5.

    Less than 1 mm of myometrium.

Color Doppler findings of placenta accreta

The presence of two or more of these signs is necessary for the diagnosis of placenta accreta:

  • 1.

    Blood flowing erratically from the placenta into the environment.

  • 2.

    Diffuse or focal flow of placental lacunae inside the parenchyma.

  • 3.

    Hypervascularity in the vesico-uterine serosal interphase.

  • 4.

    The retroplacental venous complex is prominent.

  • 5.

    Doppler vascular signal loss in the retroplacenta.

Procedure for gathering data

The three researchers reviewed the abstracts and titles after eliminating duplicates. Any conflict was solved by the fourth author. Next, we examined the entire text using the study's inclusion and exclusion criteria.

Data Collection Process: After duplicates removed, the three researchers screened the titles and abstracts. Any conflict was solved by the fourth author. Then, we investigated the full text based on inclusion and exclusion criteria for this study.

Risk of bias assessment

The bias is a systematic error, or a deviation from the truth, in results or conclusions. The different biases may lead to underestimation or overestimation of the actual intervention effect. Quality assessment of the included studies was done following the Newcastle–Ottawa Scale (NOS) [11]; the researchers were in charge to assess the methodological quality for each included study.

Literature search

The search strategy yielded 156 relevant articles, 87 articles were excluded based on their title and abstract. Fifty-two articles were retrieved (Duplicated). Ten of these articles also excluded after full text review based on inclusion, exclusion criteria and eligibility. Process is shown in detail (Figure 1) flow chart according to PRISMA guidelines. At the end, a total of 24 studies (1509 participants) ultimately met the inclusion criteria.

Figure 1.

Figure 1

Flow chart of the search and screening process

Mohamed. Accuracy of ultrasound in prediction of abnormal placental adherence: a systematic review and meta-analysis. AJOG Glob Rep 2024.

Statistical Analysis: Data entered was organized in Microsoft excel 2010 then exported to comprehensive meta-analysis software version 3.

Pooled for analysis of multiple studies, and found adjusted accumulative outcome.

Z score method: to test difference in mean.

Test for heterogeneity: Cochran's Q test and I2: Under null, it is approximately distributed as a chi-square with k-1 degrees of freedom for test heterogeneity and homogeneity of studies results and finding.

Results

A total of 24 studies, including 1509 women who met the inclusion criteria, were analyzed. Placenta accreta spectrum (PAS) was confirmed in 398 of these cases (Table 1).

Table 1.

Characteristics of studies

Reference Diagnostic tools Inclusion criteria Trimester scan Reference standard Women scan Invasion placenta
E. PILLONI et al.12 Transvaginal and transabdominal color Doppler PP and/or previous CS or uterine surgery Second and Third trimester Surgical finding 314 37
Bhawna et al.13 Ultrasound color Doppler and MRI PP and/or previous CS or uterine surgery Third trimester Pathology And Surgical Finding 30 8
J.Vojtech et al.14 Ultrasound color Doppler and MRI PP with previous CS Third trimester Pathology 18 10
A.Elgebaly et al.15 Ultrasound color Doppler and MRI PP Third trimester Surgical finding 100 34
Cali et al.16 2- and 3-dimension ultrasound color doppler PP and previous uterine surgery 2 and 3 trimesters Pathology 187 41
G. A. Kassem et al.17 2-dimension ultrasound PP e previous CS 3trimester Pathology and surgical finding 100 25
Fishman et al.18 2-dimension ultrasound Placenta previa 3trimester Pathology 154 23
Esakoff et al.19 2-dimension ultrasound Placenta previa 3trimester Pathology 108 19
Hamada et al.20 2-dimension ultrasound PP and/or previous CS 3trimester Pathology 70 5
Mansour et al.21 Ultrasound and MRI PP, previous uterine surgery 3trimester Surgical finding 35 15
Lim et al.22 Ultrasound and MRI Previous CS and/or third-trimester bleeding 2 and 3 trimesters Pathology 13 9
ElBehery et al.23 Cell free M RNA in maternal plasma e US color Doppler PP, previous CS or uterine surgery 3trimester Pathology and surgical finding 35 7
Shih et al.24 2- and 3-dimension ultrasound color doppler PP and/or previous CS or uterine surgery 3trimester Pathology 170 39
Chou et al.25 2- and 3-dimension US color Doppler PP, previous CS 2 and 3 trimesters Pathology 44 6
Wong et al.26 2-dimension ultrasound PP and/or previous CS or uterine surgery 2 and 3 trimesters Pathology and surgical finding 66 9
Dwyer et al.27 Ultrasound and MRI PP and/or previous CS or uterine surgery 3trimester Pathology and clinical finding 32 15
Minura et al.28 Cell free M RNA in maternal plasma e US PP and/or previous CS 3trimester Pathology 12 4
Japarj et al.29 Transabdominal and trans vaginal colour Doppler PP, previous CS 3trimester Pathology and surgical finding 21 7
Warshak et al.30 Ultrasound and MRI PP and/or previous CS or uterine surgery 2 and3 trimester Pathology 453 39
Yang et al.31 trans vaginal ultrasound PP, previous CS 2 and 3 trimesters Pathology 51 23
Comstock et al.32 Ultrasound colour Doppler Low anterior placenta, previous CS 2 and 3trimester Pathology 2002 4
Moodly et al.33 Ultrasound and MRI Placenta previa 3trimester Pathology and surgical finding 30 3
Chou et al.34 Ultrasound colour Doppler PP and/or previous CS or uterine surgery 2 and 3trimester Pathology 80 17
Twickler et al.35 Ultrasound colour Doppler PP, previous CS 3trimester Pathology and surgical finding 20 10

Mohamed. Accuracy of ultrasound in prediction of abnormal placental adherence: a systematic review and meta-analysis. AJOG Glob Rep 2024.

Timing of Ultrasound Diagnosis

In 15 studies, all ultrasound diagnoses were performed during the third trimester.13, 14, 15, 16, 17, 18, 19, 20, 21,23,24,27, 28, 29,33,35 In contrast, 9 studies included diagnoses performed during both the second and third trimesters.12,16,22,25,26,30,31,32,34

Diagnostic Performance of Specific Ultrasound Signs

The sensitivity and specificity of individual ultrasound characteristics for PAS were evaluated across different studies:

  • 1.

    Placental Lacunae:This characteristic was assessed in 11 studies.16,20,21,23,24,26,28,29,31,32,35 The pooled sensitivity was 91.73% (95% CI: 88.3–94.7), and the specificity was 97.95% (95% CI: 97.4–98.6).

  • 2.

    Lack of Clear Zone:

    The absence of a clear zone between the placenta and uterine wall was evaluated in 9 studies.16,20,21,23,24,26,28,29,30 This sign demonstrated moderate diagnostic accuracy, with detailed sensitivity and specificity shown in Table 3.

  • 3.

    Uterus–Bladder Interface:

    Distortion or interruption of the uterus–bladder interface was examined in 7 studies.16,23, 24, 25, 26,29,35 The findings are summarized in Table 4.

  • 4.

    Color Doppler Findings:

    Abnormal vascular patterns on color Doppler imaging, including turbulent flow and increased vascularity, were evaluated in 12 studies.23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33,36 Among all ultrasound modalities, color Doppler showed the highest predictive accuracy, with a pooled sensitivity of 91.75% (95% CI: 86.3–95.6) and specificity of 87.69% (95% CI: 85.7–91.5).

Table 3.

The sensitivity and specificity of lack of clear zone in the studies

Author names Sensitivity of lack of clear zone Specificity of lack of clear zone
Cali et al.16 90% 81%
Mansour et al.21 87% 81%
Hamada et al.20 60% 98%
El Behery et al.23 100% 89%
Shih et al.24 44% 95%
Miura et al.28 100% 25%
Wong et al.26 100% 35%
Japaraj et al.29 43% 100%
Comstock et al.32 60% 99%

Mohamed. Accuracy of ultrasound in prediction of abnormal placental adherence: a systematic review and meta-analysis. AJOG Glob Rep 2024.

Table 4.

The sensitivity and specificity of the uterus–bladder interface in the studies

Author names Sensitivity of uterus – bladder interface Specificity of uterus – bladder interface
Cali et al.16 71% 99%
El Behery et al.23 43% 96%
Shih et al.24 18% 100%
Chou et al.25 100% 100%
Wong et al.26 11% 100%
Japaraj et al.29 57% 100%
Twickler et al.35 90% 70%

Mohamed. Accuracy of ultrasound in prediction of abnormal placental adherence: a systematic review and meta-analysis. AJOG Glob Rep 2024.

Overall diagnostic performance of ultrasound

Ultrasound as a diagnostic tool for invasive placentation showed high overall accuracy:

  • Sensitivity: 91.73% (95% CI: 88.3–94.7)

  • Specificity: 97.95% (95% CI: 97.4–98.6)

  • Positive Likelihood Ratio (LR+): 12.02 (95% CI: 6.2–21.1)

  • Negative Likelihood Ratio (LR–): 0.17 (95% CI: 0.12–0.24)

  • Diagnostic Odds Ratio (DOR): 99.6 (95% CI: 49.9–200.0)

Among the evaluated ultrasound characteristics, color Doppler demonstrated the best predictive accuracy, with a sensitivity of 91.75% and a specificity of 87.69%. Other ultrasound signs, such as placental lacunae, lack of a clear zone, and abnormalities in the uterus–bladder interface, also contributed to diagnosis but with varying levels of sensitivity and specificity (Table 2, Table 3, Table 4, Table 5, Table 6, Table 7).

Table 2.

The sensitivity and specificity of placental lacunae in the studies

Author names Sensitivity of placental lacunae Specificity of placenta lacunae
Cali et al.16 73% 86%
Mansour et al.21 87% 81%
Hamada et al.20 60% 71%
El Behery et al.23 86% 93%
Shih et al.24 54% 85%
Miura et al.28 100% 25%
Wong et al.26 78% 39%
Japaraj et al.29 86% 100%
Yang et al.31 87% 79%
Twickler et al.35 100% 70%
Comstock et al.32 80% 100%

Mohamed. Accuracy of ultrasound in prediction of abnormal placental adherence: a systematic review and meta-analysis. AJOG Glob Rep 2024.

Table 5.

The sensitivity and specificity of ultrasound in the studies

Author names Sensitivity of US Specificity of US
E. PILLONI et al.12 73.13% 95.5%
Bhawna et al.13 53.3% 88%
J.Vojtech et al.14 87.5% 86.4%
A.Elgebaly et al.15 53.5% 82%
Cali et al.16 100% 37.5%
G. A. Kassem et al.17 95% 95%
Fishman et al.18 91% 100%
Esakoff et al.19 89% 91%
Hamada et al.20 60% 98%
Mansour et al.21 87% 80%
Lim et al.22 67% 50%
El Behery et al.23 100% 79%
Shih et al.24 100% 85%
Chou et al.25 100% 100%
Wong et al.26 89% 98%
Dwyer et al.27 93% 71%
Minura et al.28 100% 63%
Japarj et al.29 100% 100%
Warshak et al.30 77% 96%
Yang et al.31 87% 79%
Comstock et al.32 100% 99%
Moodly et al.33 67% 93%
Chou et al.34 82% 97%
Twickler et al.35 100% 60%

Mohamed. Accuracy of ultrasound in prediction of abnormal placental adherence: a systematic review and meta-analysis. AJOG Glob Rep 2024.

Table 6.

The sensitivity and specificity of colour Doppler in the studies

Author names Sensitivity of colour dopper Specificity of colour Doppler
El Behery et al.23 76.7% 90.4%
Shih et al.24 90% 100%
Chou et al.25 76% 90%
Wong et al.26 86% 96%
Dwyer et al.27 100% 100%
Minura et al.28 100% 85%
Japarj et al.29 100% 50%
Warshak et al.30 88% 41%
Yang et al.31 100% 100%
Comstock et al.32 67% 85%
Moodly et al.33 100% 60%

Mohamed. Accuracy of ultrasound in prediction of abnormal placental adherence: a systematic review and meta-analysis. AJOG Glob Rep 2024.

Table 7.

Pooled values for sensitivity, specificity, positive and negative likelihood ratios (LR and LR–), and diagnostic odds ratio (DOR) for ultrasound overall, and the different ultrasound signs in the identification of invasive placentation

Diagnostic method Sensitivity (95% CI) (%) Specificity (95% CI) (%) LR+ (95% CI) LR- (95% CI) DOR (95% CI)
Ultrasound (overall) 91.73 (88.3– 94.7) 97.95 (97.4– 98.6) 12.02 (7.2– 21.1) 0.17 (0.12– 0.24) 99.6 (49.9– 200.1)
Placental lacunae 78.43 (71.2– 84.2) 96.03 (95.2– 96.9) 5.53 (3.6– 9.2) 0.30 (0.21– 0.44) 25.33 (10.14– 65.9)
Loss of hypoechoic space 67.25 (60.4– 74.7) 96.77 (95.2– 97.6) 6.65 (3.4– 15.2) 0.39 (0.21– 0.7) 22.99 (7.9– 71.7)
Abnormalities of uterus– bladder interface 50.67 (42.5– 59.0) 99.77 (99.6– 99.9) 31.57 (9.2– 116.6) 0.52 (0.35– 0.78) 94.71 (36.6– 248.6)
Color Doppler abnormalities 91.75 (86.3– 95.8) 88.69 (85.7– 91.5) 8.78 (4.4– 19.5) 0.18 (0.11– 0.3) 70.03 (23.9– 209.2)

Mohamed. Accuracy of ultrasound in prediction of abnormal placental adherence: a systematic review and meta-analysis. AJOG Glob Rep 2024.

Discussion

Principal findings

This systematic review and meta-analysis demonstrates that ultrasonography, especially with the use of color Doppler, is a highly accurate diagnostic tool for the detection of placenta accreta spectrum (PAS) in high-risk pregnancies. The pooled specificity and sensitivity of ultrasound were 97.95% and 91.73%, respectively, confirming its robustness in prenatal detection. In comparison, Color Doppler outperformed other modalities with a sensitivity of 91.75% and specificity of 88.69%. These findings are based on data from 24 studies that involved 1,509 pregnancies and are reflective of the strong diagnostic value of ultrasonography for PAS.

Results in the context of what is known

The findings of our study align with prior research emphasizing the diagnostic utility of ultrasonography in invasive placentation. Previous studies have reported specificity and sensitivity rates which are comparable to those found in this analysis, highlighting the consistency of ultrasound's performance. For instance, studies have emphasized the effectiveness of color Doppler and grayscale ultrasonography in identifying features such as loss of the hypoechoic zone, abnormal vascular patterns, and placental lacunae. While some studies suggested MRI as a potential adjunct, the current evidence supports ultrasonography as the primary tool due to its accessibility, reliability, and non-invasive nature.

Clinical implications

This study's findings underscore the clinical value of ultrasonography in the early detection of PAS, allowing for strategic and timely clinical decision-making. Early identification facilitates multidisciplinary management plans like scheduled cesarean delivery, advanced surgical preparation, and interventional radiology in order to mitigate risks such as massive hemorrhage and maternal morbidity. These results support the integration of detailed ultrasonographic evaluation, including color Doppler, into routine care for high-risk pregnancies. However, further research is needed for standardizing diagnostic protocols and confirming the applicability of these findings across diverse clinical settings and populations.

Research implications

Despite the strong diagnostic accuracy of ultrasonography for PAS, several questions remain unanswered. Future research should explore its utility in fundal and posterior placentas, which were excluded in most studies. Additionally, prospective, blinded studies are needed to minimize bias and improve the generalizability of findings. Research is also warranted for comparing ultrasonography with alternative modalities like MRI in specific high-risk subgroups and to refine criteria for diagnosis, particularly in cases with ambiguous ultrasound findings.

Strengths and limitations

The study's strengths include a rigorous systematic approach, comprehensive data analysis, and inclusion of diverse ultrasound modalities, enhancing the reliability of the findings. However, limitations exist. Variability in study design and ultrasound protocols across included studies may have introduced heterogeneity. Many studies were retrospective, which could bias the results, and blinding was not consistently reported. Moreover, the findings are limited to anterior placentas in high-risk women, excluding those with fundal or posterior placentas.

Conclusions

Ultrasonography, particularly when combined with color Doppler, is highly accurate in diagnosing PAS in high-risk pregnancies. This diagnostic tool allows for early detection and better clinical management, ultimately reducing maternal morbidity. However, standardization of diagnostic criteria and further research addressing current limitations are necessary to optimize its application in clinical practice.

CRediT authorship contribution statement

Ekramy A. Mohamed: Writing – review & editing, Visualization, Validation, Supervision, Resources, Project administration, Methodology, Investigation, Formal analysis, Data curation. Ruqayyah Ali Ahmed: Writing – review & editing, Writing – original draft, Validation, Software, Resources, Project administration, Methodology, Investigation, Formal analysis, Data curation. Nada Yasser Metwali: Writing – original draft, Validation, Resources, Project administration, Methodology, Investigation, Formal analysis, Data curation. Jumana Hussain Timraz: Writing – original draft, Validation, Software, Project administration, Methodology, Investigation, Formal analysis, Data curation. Ahmed Mohamed: Writing – original draft, Data curation, Investigation, Writing – review & editing, Methodology, Software. Hossam Abdelfatah Mansour: Writing – review & editing, Writing – original draft, Visualization, Validation, Supervision, Software, Resources, Project administration, Methodology, Investigation, Formal analysis, Data curation, Conceptualization.

Acknowledgments

Acknowledgments

Not applicable

Footnotes

Tweetable Statement: Ultrasound, especially with color Doppler, demonstrates high diagnostic accuracy for placenta accreta spectrum (PAS) in high-risk pregnancies, with a pooled sensitivity of 91.73% and specificity of 97.95%.

The authors report no conflict of interest. No funding was received.

Availability of data and materials: The data generated in the present study are included in the figures and/or tables of this article.

Ethical approval and consent to participate: Not applicable.

Contributor Information

Ruqayyah Ali Ahmed, Email: ruqayyahali9@gmail.com.

Hossam Abdelfatah Mansour, Email: hosam.mansour1257@gmail.com.

References

  • 1.Usta I.M., Hobeika E.M., Abu Musa A.A., Gabriel G.E., Nassar A.H. Placenta previa-accreta: risk factors and complications. Am J Obstet Gynecol. 2005;193(3 SUPPL):1045–1049. doi: 10.1016/j.ajog.2005.06.037. [DOI] [PubMed] [Google Scholar]
  • 2.Wu S., Kocherginsky M., Hibbard J.U. Abnormal placentation: twenty-year analysis. Am J Obstet Gynecol. 2005;192(5):1458–1461. doi: 10.1016/j.ajog.2004.12.074. [DOI] [PubMed] [Google Scholar]
  • 3.Bartels H.C., Postle J.D., Downey P., Brennan D.J. Placenta accreta spectrum: a review of pathology, molecular biology, and biomarkers. Dis Markers. 2018 doi: 10.1155/2018/1507674. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Pinas-Carrillo A., Chandraharan E. Management of morbidly adherent placenta. Obstet Gynaecol Reproduc Med. 2016;26(10):283–290. [Google Scholar]
  • 5.Marcellin L., Delorme P., Bonnet M.P., Grange G., Kayem G., Tsatsaris V., Goffinent F. placenta percreta is associated with more frequent sever maternal morbidly than placenta accrete. Amj Obstet Gynecol. 2018;219:193.e1–193.e9. doi: 10.1016/j.ajog.2018.04.049. [DOI] [PubMed] [Google Scholar]
  • 6.Chong Y., Zhang A., Wang Y., Chen Y., Zhao Y. An ultrasonic scoring system to predict the prognosis of placenta accreta: a prospective cohort study. Medicine. 2018;97(35):e12111. doi: 10.1097/MD.0000000000012111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Shawky M., AbouBieh E., Masood A. Gray scale and Doppler ultrasound in placenta accreta: optimization of ultrasound signs. Egyptian J Radiol Nuclear Medic. 2016;47(3):1111–1115. [Google Scholar]
  • 8.Shamshirsaz A.A., Fox K.A., Salmanian B., et al. Maternal morbidity in patients with morbidly adherent placenta treated with and without a standardized multidisciplinary approach. Am J Obstet Gynecol. 2015;212(2):218.e1–218.e9. doi: 10.1016/j.ajog.2014.08.019. [DOI] [PubMed] [Google Scholar]
  • 9.Jauniaux E., Bhide A., Kennedy A., Woodward P., Hubinont C., Collins S. FIGO consensus guidelines on placenta accreta spectrum disorders: prenatal diagnosis and screening. Int J Gynaecol Obstet Off organ Int Fed Gynaecol Obstet. 2018;140(3):274–280. doi: 10.1002/ijgo.12408. [DOI] [PubMed] [Google Scholar]
  • 10.Okumura R., Francisco P., Kondo M.M., et al. Ultrasound diagnosis and evaluation of the number of prior Caesarean deliveries as risk factor for placenta accreta in placenta previa cases. Ultrasound Obstet Gynecol. 2016;48:323. doi: 10.1002/uog.16974. [DOI] [Google Scholar]
  • 11.Maged A.M., Abdelaal H., Salah E., et al. Prevalence and diagnostic accuracy of Doppler ultrasound of placenta accreta in Egypt. J Matern Neonatal Med. 2018;31(7):933–939. doi: 10.1080/14767058.2017.1303667. [DOI] [PubMed] [Google Scholar]
  • 12.Pilloni E., Alemanno M.G., Gaglioti P., et al. Accuracy of ultrasound in antenatal diagnosis of placental attachment disorders. Ultrasound Obstet Gynecol. 2016;47:302–307. doi: 10.1002/uog.14893. [DOI] [PubMed] [Google Scholar]
  • 13.Bhawna Z.S., Alexandra Eller G., Kennedy M., et al. Accuracy of ultrasound for the prediction of placenta accreta. AM J Obstet Gynecol. 2014;177:323. doi: 10.1016/j.ajog.2014.03.029. [DOI] [PubMed] [Google Scholar]
  • 14.Vojtech J., Pock R., Haslik L., et al. Placenta praevia after previous Caesarean section risk stratification: ultrasound versus MRI. Ultrasound Obstetr Gynecol. 2014;44(Suppl. 1):62–180. [Google Scholar]
  • 15.Algebally AM., Yousef R.R.H., Badr S.S.H., Obeidly A-Al, Szmigielski W., Al Ibrahim AA. The value of ultrasound and magnetic resonance imaging in diagnostics and prediction of morbidity in cases of placenta previa with abnormal placentation. Pol J Radiol. 2014;79:409–416. doi: 10.12659/PJR.891252. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Calí G., Giambanco L., Puccio G., Forlani F. Morbidly adherent placenta: evaluation of ultrasound diagnostic criteria and differentiation of placenta accreta from percreta. Ultrasound Obstet Gynecol; 2013;41:406–412. doi: 10.1002/uog.12385. [DOI] [PubMed] [Google Scholar]
  • 17.Kassem Gamal A, Alzahrani Ali K. Maternal and neonatal outcomes of placenta previa and placenta accreta: three years of experience with a two-consultant approach. Int J Womens Health. 2013;5:803–810. doi: 10.2147/IJWH.S53865. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Fishman S.G., Chasen S.T. Risk factors for emergent preterm delivery in women with placenta previa and ultrasound findings suspicious for placenta accreta. J Perinat Med. 2011;39:693–696. doi: 10.1515/jpm.2011.086. [DOI] [PubMed] [Google Scholar]
  • 19.Esakoff T.F., Sparks T.N., Kaimal A.J., et al. Diagnosis and morbidity of placenta accreta. Ultrasound Obstet Gynecol. 2011;37:324–327. doi: 10.1002/uog.8827. [DOI] [PubMed] [Google Scholar]
  • 20.Hamada S., Hasegawa J., Nakamura M., et al. Ultrasonographic findings of placenta lacunae and a lack of a clear zone in cases with placenta previa and normal placenta. Prenatal Diagnosis. 2011;31(11):1062–1065. doi: 10.1002/pd.2833. [DOI] [PubMed] [Google Scholar]
  • 21.Mansour S.M., Elkhyat WM. Placenta previa - Accreta: Do we need MR imaging? Egypt J Radiol Nucl Med. 2011;42(3–4):433–442. [Google Scholar]
  • 22.Lim P.S., Greenberg M., Edelson M.I., Bell K.A., Edmonds P.R., Mackey A. Utility of ultrasound and MRI in prenatal diagnosis of placenta accreta: a pilot study. AJR Am JRoentgenol. 2011;197:1506–1513. doi: 10.2214/AJR.11.6858. [DOI] [PubMed] [Google Scholar]
  • 23.El Behery M.M., Rasha L.E., El Alfy Y. Cell-free placental mRNA in maternal plasma to predict placental invasion in patients with placenta accreta. Int J Gynaecol Obstet. 2010;109:30–33. doi: 10.1016/j.ijgo.2009.11.013. [DOI] [PubMed] [Google Scholar]
  • 24.Shih J.C., Jaraquemada J.M.P., Su Y.N., et al. Role of three-dimensional power Doppler in the antenatal diagnosis of placenta accreta: Comparison with gray-scale and color Doppler techniques. Ultrasound Obstet Gynecol. 2009;33(2):193–203. doi: 10.1002/uog.6284. [DOI] [PubMed] [Google Scholar]
  • 25.Chou M.M., Chen W.C., Tseng J.J., Chen Y.F., Yeh T.T., Ho E.S. Prenatal detection of bladder wall involvement in invasive placentation with sequential two-dimensional and adjunctive three-dimensional ultrasonography. Taiwan J Obstet Gynecol. 2009;48:38–45. doi: 10.1016/S1028-4559(09)60033-4. [DOI] [PubMed] [Google Scholar]
  • 26.Wong H S, Cheung Y K, Zuccollo J., Tait J., Pringle K C. Evaluation of sonographic diagnostic criteria for placentaaccreta. J Clin Ultrasound. 2008;36:551–559. doi: 10.1002/jcu.20524. [DOI] [PubMed] [Google Scholar]
  • 27.Dwyer B.K., Belogolovkin V., Tran L., Rao A., Carroll I., Barth R., Chitkara U. Prenatal diagnosis of placenta accreta: sonographyor magnetic resonance imaging? J Ultrasound Med. 2008;(27):1275–1281. doi: 10.7863/jum.2008.27.9.1275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Miura K., Miura S., Yamasaki K., et al. Increased level of cell-free placental mRNA in a subgroup of placenta previa that needs hysterectomy. Prenat Diagn. 2008;(28):805–809. doi: 10.1002/pd.2056. [DOI] [PubMed] [Google Scholar]
  • 29.Japaraj R.P., Mimin T.S., Mukudan K. Antenatal diagnosis of placenta previa accreta in patients with previous cesarean scar. J Obstet Gynaecol Res. 2007;(33):431–437. doi: 10.1111/j.1447-0756.2007.00549.x. [DOI] [PubMed] [Google Scholar]
  • 30.Warshak C.R., Eskander R., Hull A.D., et al. Accuracy of ultrasonography and magnetic resonance imaging in the diagnosis of placenta accreta. Obstet Gynecol. 2006;(108):573–581. doi: 10.1097/01.AOG.0000233155.62906.6d. [DOI] [PubMed] [Google Scholar]
  • 31.Yang J.I., Lim Y.K., Kim H.S., Chang K.H., Lee J.P., Ryu H.S. Sonographic findings of placental lacunae and the prediction of adherent placenta in women with placenta previa totalis and prior Cesarean section. Ultrasound ObstetGynecol. 2006;(28):178–182. doi: 10.1002/uog.2797. [DOI] [PubMed] [Google Scholar]
  • 32.Comstock C.H., Bronsteen RA. The antenatal diagnosis of placenta accreta. BJOG. 2014;121(2):171–172. doi: 10.1111/1471-0528.12557. [DOI] [PubMed] [Google Scholar]
  • 33.Moodley J., Ngambu N.F., Corr P. Imaging techniques to identify morbidly adherent placenta praevia: a prospective study. JObstet Gynaecol. 2004;(24):742–744. doi: 10.1080/01443610400009402. [DOI] [PubMed] [Google Scholar]
  • 34.Chou M.M., Ho E.S., Lee Y.H. Prenatal diagnosis of placenta previa accreta by transabdominal colour Doppler ultrasound. Ultrasound Obstet Gynecol. 2000;(15):28–35. doi: 10.1046/j.1469-0705.2000.00018.x. [DOI] [PubMed] [Google Scholar]
  • 35.Twickler D.M., Lucas M.J., Balis A.B., et al. Colour flow mapping for myometrial invasion in women with a prior cesarean delivery. J Mater Fetal Med. 2000;(9):330–335. doi: 10.1002/1520-6661(200011/12)9:6<330::AID-MFM1002>3.0.CO;2-O. [DOI] [PubMed] [Google Scholar]
  • 36.Bodner L.J., Nosher J.L., Gribbin C., Siegel R.L., Scorza B.S. Balloon-assisted occlusion of the internal iliac arteries in patients with placenta accreta/percreta. Cardiovasc Intervent Radiol. 2006;(29):354–361. doi: 10.1007/s00270-005-0023-2. [DOI] [PubMed] [Google Scholar]

Articles from AJOG Global Reports are provided here courtesy of Elsevier

RESOURCES